Non-valvular atrial fibrillation
Conditions
Interventions
Conventional Treatment Group
Near-Zero Treatment Group
Sponsors
other
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: From the date of approval by the head of the research institution until December 31, 2024, patients undergoing their first catheter ablation for non-valvular atrial fibrillation at the Department of Cardiology, Nippon Medical School Hospital, who have been provided with an explanation of this study using an informed consent document and have given their consent, will be included in the study.
Exclusion criteria
Exclusion criteria: Individuals with underlying heart diseases such as valvular disease or cardiomyopathy; those with a history of catheter ablation for non-valvular atrial fibrillation; individuals who are pregnant or wish to become pregnant. However, men whose partners wish to become pregnant will not be considered exclusion criteria. Additionally, individuals deemed inappropriate for participation in this study by the principal investigator or co-investigators will also be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Presence or absence of atrial fibrillation recurrence within one year after treatment | — |
Countries
Japan
Contacts
Public ContactYuki Iwasaki
Nippon Medical School Cardiovascular Medicine
Outcome results
None listed